The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
November 25th 2024
Findings highlight the unmet medical need for outpatient interventions and preventive measures that can reduce hospitalizations.
Expert: NIH Encourages Data from Clinical Trials be Disaggregated by Sex in Reporting
December 24th 2021Sarah Temkin, MD, associate director for clinical research in the Office of Research on Women’s Health at the National Institutes of Health, discusses how clinical trials have evolved to address biological and sociological variables in patient health.
Watch
The Psychedelic Drugs Currently Under Investigation for Potential FDA Approval
December 24th 2021Ismail Lourido Ali, JD, director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses which psychedelic drugs are currently under investigation for potential FDA approval.
Watch
Expert: US Drug Shortages May Not Be Associated With Problems in the Global Supply Chain
December 24th 2021Andrew Mulcahy, PhD, a senior policy researcher at RAND Corporation, discusses a recent report that showed the drug shortages in the United States may not be associated with problems in the global supply chain.
Watch
Expert: 'We Cannot Overstate or Ignore' Relationship Between Diabetes, COVID-19 Infection Risk
December 24th 2021Laura Lee Hall, PhD, president of the Center for Sustainable Health Care Quality and Equity (SHC), addresses how the diabetes DRIVE program compares with the SHC DRIVE models for flu and COVID-19 vaccinations.
Watch
Semaglutide Carries Potential Risk of Worsening Diabetic Retinopathy
Despite demonstrating numerous benefits, semaglutide has also been linked to an increased incidence of diabetic retinopathy, which was initially reported in the SUSTAIN-6 trial.
Read More
Expert: Pharmacists, USP Worked Together ‘A Hundred Times Faster Than Ever Before’ in 2021
December 22nd 2021Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, explains how pharmacists and USP came together in 2021 to work harder than ever before, as well as what can be done now to prepare for the next health crisis.
Watch
TXNIP inhibitors: A New Class of Agents for Diabetes Treatment
TXNIP inhibition could prevent beta cell loss and protect beta cell function to potentially contribute to diabetes management and its complications.
Read More